Regional Hepatic Chemotherapies in Treatment of Colorectal Cancer Metastases to the Liver

  • Ammori J
  • Kemeny N
  • 33


    Mendeley users who have this article in their library.
  • 9


    Citations of this article.


Colorectal cancer metastases to the liver are primarily supplied by the hepatic artery. Therefore, delivery of regional chemotherapy via the hepatic artery is a viable treatment option. Chemotherapy can be delivered in high concentration to the liver with minimal systemic toxicity. Hepatic artery infusional (HAI) chemotherapy both alone and in combination with systemic chemotherapy in the treatment of isolated hepatic metastases from colorectal cancer has resulted in high response rates and increased resection rates for previously unresectable liver disease. Regional chemotherapy can also be used as adjuvant treatment after complete resection of liver metastases to reduce hepatic recurrences. The combination of HAI therapy with modern systemic chemotherapy has a role in the palliative, adjuvant, and neoadjuvant settings. © 2010 Elsevier Inc. All rights reserved.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • John B. Ammori

  • Nancy E. Kemeny

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free